awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50075257-0D8E69BA-3D7C-4A32-AAE5-23A852FF3059
Q50075257-0D8E69BA-3D7C-4A32-AAE5-23A852FF3059
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50075257-0D8E69BA-3D7C-4A32-AAE5-23A852FF3059
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials.
P2860
Q50075257-0D8E69BA-3D7C-4A32-AAE5-23A852FF3059
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50075257-0D8E69BA-3D7C-4A32-AAE5-23A852FF3059
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
35ecd855bfbf2d92ae422488b47f64bf3ae1bc1d
P2860
Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors.